Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2006

01-11-2006 | Poster Presentation

Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy

Authors: T Friedberg, E Polson, S Weidlich

Published in: Breast Cancer Research | Special Issue 2/2006

Login to get access

Excerpt

Mammary cancer can develop for many reasons; one is the exposure to environmental carcinogens and/or steroid hormones. The cytochrome P450 enzyme family catalyses not only the metabolism of a wide range of carcinogens but is also involved in the metabolism of steroids. This process alters their steroidogenic properties, a mechanism important for mammary carcinogenesis. …
Metadata
Title
Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy
Authors
T Friedberg
E Polson
S Weidlich
Publication date
01-11-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1581

Other articles of this Special Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue

Poster Presentation

High-grade ER-negative tumour breast cancers are characteristic of both very young onset cases and patients with hereditary breast cancer

Poster Presentation

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer

Poster Presentation

Role of protein kinase B in breast cancer

Oral Presentation

Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications

Oral Presentation

Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1

Poster Presentation

Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits